Category: Press Release

Full color logo for Avobis Bio

Avobis transforms life for patients with debilitating conditions by harnessing the power of implantable biology to develop curative therapies for healing tissues.

Linkedin-in

551 Paper Mill Rd.
Newark, DE 19711 

©2026 Avobis Bio, LLC. All Rights Reserved.

Mayo and Mayo Clinic are trademarks of Mayo Foundation for Medical Education and Research. GORE and designs are trademarks of W. L. Gore & Associates. 

Caution: New Drug – Limited by United States law to investigational use. Safety and effectiveness have not been established. This investigative product is not commercially available in any markets.

Biotech Website Design
Linkedin-in
Linkedin-in

Tiffany J. Brown, PhD

Chief Executive Officer

Tiffany leads Avobis Bio as Chief Executive Officer, Chief Compliance Officer and Board Member. She has been passionate about regenerative medicine for 25 years and focused her career on ensuring patients have access to therapies to transform their lives. In her early career, Tiffany developed new products from clinical concept through technology development, global regulatory approvals and commercial sales. She went on to lead a multi-million dollar global portfolio of therapeutics for general surgical, bariatric and colorectal conditions with assets from pre-clinical stage to market leaders. Tiffany was instrumental in the formation of Avobis Bio, bringing together capabilities of Gore and Mayo Clinic, establishing the team and accelerating operational execution. She holds a PhD in Biomedical Engineering from Georgia Tech and Emory University. Tiffany enjoys immersion in global cultures, opportunities to travel and staying active with her husband and children.